- Carlsmed (CARL) has priced its initial public offering at $15 per share, offering 6.7 million shares and aiming to raise around $100.5 million in gross proceeds, excluding any underwriters’ option.
- Shares will trade on Nasdaq under the ticker “CARL” starting July 23, 2025, with the offering expected to close the following day.
- Underwriters have a 30-day option to buy up to 1.005 million additional shares.
- Carlsmed is a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions.
